Paper Details

  1. Home
  2. Paper Details

Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group.

Author: BoccadoroMario, CibeiraM Teresa, GibbsSimon D, JaccardArnaud, KastritisEfstathios, KumarShaji, MerliniGiampaolo, PalladiniGiovanni, SanchorawalaVaishali, SchönlandStefan, VennerChristopher, WechalekarAshutosh D

GuidelineRecommendations and best practices developed by experts for healthcare professionals to refer to when making clinical judgments and providing care.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

These guidelines from the European Society of Haematology and International Society of Amyloidosis recommend non-transplant chemotherapy treatment for patients with AL amyloidosis. Treatment selection should consider clinical presentation, treatment tolerance, potential side effects, and patient fitness. Daratumumab-VCD is recommended for most untreated patients.
Paper Details　
Original Abstract of the Article :
BACKGROUND: This guideline has been developed jointly by the European Society of Haematology and International Society of Amyloidosis recommending non-transplant chemotherapy treatment for patients with AL amyloidosis. METHODS: A review of literature and grading of evidence as well as expert recomm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/13506129.2022.2093635

データ提供：米国国立医学図書館（NLM）

A New Oasis in the Desert of AL Amyloidosis: Guidelines for Non-Transplant Chemotherapy

This research provides comprehensive guidelines for treating [systemic AL amyloidosis], a complex and challenging condition. It's like creating a map to guide us through the vast desert of this illness, offering hope and direction for those seeking treatment.

Navigating the Desert of AL Amyloidosis: Guidelines for Treatment

The guidelines outline the latest evidence-based recommendations for the treatment of [AL amyloidosis], offering a roadmap for healthcare professionals to guide patients through their journey. It's like discovering a new oasis of knowledge in the desert of this disease, providing a framework for optimal care.

A Desert of Challenges: Finding Hope in AL Amyloidosis

This research underscores the importance of ongoing research into the treatment of [AL amyloidosis]. It's like seeking new solutions in the vast desert of this disease, constantly striving for better therapies and improved outcomes for patients.

Dr.Camel's Conclusion

This research is a valuable resource for both patients and healthcare professionals facing the challenges of [AL amyloidosis], offering guidance and hope in the midst of a complex and difficult journey. It's a reminder that even in the desert of illness, there can be oases of knowledge, compassion, and hope.

Date :
  1. Date Completed 2023-03-15
  2. Date Revised 2023-03-15
Further Info :

Pubmed ID

35838162

DOI: Digital Object Identifier

10.1080/13506129.2022.2093635

Related Literature

Article Analysis
・Side Effects of venetoclax
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.